← back to search

Mark Connors

National Institute of Allergy and Infectious Diseases · US
Area of research
Immunology · Virology
Research interest
Research interests include HIV Research and Treatment, Immune Cell Function and Interaction, T-cell and B-cell Immunology, and Cytomegalovirus and herpesvirus research.
h-index
75
citations
26,943
works
191
NIH funding
primary concept
Biology
email

Recent publications

Intranasal replicating adenovirus type 4-vectored SARS-CoV-2 vaccines induce durable and efficacious responses in preclinical testing
iScience 2026cited by 1position: contributordoi
A Single Dose Study of Pembrolizumab in People With HIV Infection Who are Immunologic Nonresponders.
2026cited by 0position: contributordoi
Safety, immunovirological, and CNS effects of PD-1 inhibition in people with HIV without malignancy.
2026cited by 0position: contributordoi
Transgene Expression Kinetics and Replication Potential of Recombinant Adenovirus Serotype 4 in a Mouse Model and its Use as a Herpes Simplex Virus Vaccine
2026cited by 0position: contributordoi
Inclusion of a retroviral protease enhances the immunogenicity of VLP-forming mRNA vaccines against HIV-1 or SARS-CoV-2 in mice.
2025cited by 4position: contributordoi
Incorporation of 5-methylcytidine alleviates RIG-I-mediated innate immune responses to a self-amplifying RNA vaccine.
2025cited by 1position: contributordoi
Antigen persistence and TLR stimulation contribute to induction of a durable HIV-1-specific neutralizing antibody response.
2025cited by 0position: contributordoi
Antigen Dose and Persistence Contribute to Induction of a Durable HIV-1-Specific Neutralizing Antibody Response
2024cited by 0position: contributordoi
HIV vaccines induce CD8<sup>+</sup> T cells with low antigen receptor sensitivity.
2023cited by 16position: contributordoi
Trispecific antibody targeting HIV-1 and T cells activates and eliminates latently-infected cells in HIV/SHIV infections.
2023cited by 13position: contributordoi
A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity
Journal of Clinical Investigation 2021cited by 71position: contributordoi
SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn.
2021cited by 60position: contributordoi
Immunologic Control of HIV-1: What Have We Learned and Can We Induce It?
2021cited by 7position: contributordoi
Prolonged evolution of the memory B cell response induced by a replicating adenovirus-influenza H5 vaccine
Science Immunology 2019cited by 67position: lastdoi
Prolonged evolution of the memory B cell response induced by a replicating adenovirus-influenza H5 vaccine.
2019cited by 55position: contributordoi
Toll-like receptor 7-adapter complex modulates interferon-α production in HIV-stimulated plasmacytoid dendritic cells.
2019cited by 6position: contributordoi
Inference of the HIV-1 VRC01 Antibody Lineage Unmutated Common Ancestor Reveals Alternative Pathways to Overcome a Key Glycan Barrier
Immunity 2018cited by 78position: middledoi
MAdCAM costimulation through Integrin-α4β7 promotes HIV replication
Mucosal Immunology 2018cited by 30position: middledoi
Virus-like Particles Identify an HIV V1V2 Apex-Binding Neutralizing Antibody that Lacks a Protruding Loop
Immunity 2017cited by 87position: middledoi
Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G
Cell 2016cited by 438position: middledoi
Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth
Immunity 2016cited by 392position: lastdoi
Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody
Science 2016cited by 377position: middledoi
Multiple Origins of Virus Persistence during Natural Control of HIV Infection
Cell 2016cited by 183position: middledoi
Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors
Cell 2015cited by 335position: middledoi
Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer
PLoS Pathogens 2015cited by 103position: middledoi
Reversible Reprogramming of Circulating Memory T Follicular Helper Cell Function during Chronic HIV Infection
The Journal of Immunology 2015cited by 72position: middledoi
A Subset of CD4/CD8 Double-Negative T Cells Expresses HIV Proteins in Patients on Antiretroviral Therapy
Journal of Virology 2015cited by 66position: middledoi
Neutralization Properties of Simian Immunodeficiency Viruses Infecting Chimpanzees and Gorillas
mBio 2015cited by 31position: middledoi
Selective Loss of Early Differentiated, Highly Functional PD1high CD4 T Cells with HIV Progression
PLoS ONE 2015cited by 22position: middledoi
Structure and immune recognition of trimeric pre-fusion HIV-1 Env
Nature 2014cited by 772position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 13 papers (2019–2026)Stephen A. Migueles · National Institute of Allergy and Infectious Diseases6 papers (2012–2018)Nicole A. Doria‐Rose · National Institutes of Health5 papers (2012–2023)Daniel C. Rogan · National Institute of Allergy and Infectious Diseases5 papers (2021–2025)Peter D. Kwong · National Institutes of Health3 papers (2012–2025)John R. Mascola · ApeX Therapeutics (United States)3 papers (2012–2018)Nathaniel E. Wright · National Institute of Allergy and Infectious Diseases3 papers (2019–2025)Kenta Matsuda · National Defense Medical College Hospital3 papers (2021–2025)Yaroslav Tsybovsky · National Cancer Institute3 papers (2024–2025)Stephen A. Migueles · National Institute of Allergy and Infectious Diseases3 papers (2023–2026)Jonathan D. Webber · National Institute of Allergy and Infectious Diseases3 papers (2024–2025)Takuya Yamamoto · University of California, Santa Barbara2 papers (2014–2015)Barton F. Haynes · Duke University School of Medicine2 papers (2012–2018)Julie A. Ake · Walter Reed Army Institute of Research2 papers (2014–2015)Kristin L. Boswell · National Institute of Allergy and Infectious Diseases2 papers (2014–2015)Robert Paris · Moderna Therapeutics (United States)2 papers (2014–2015)Constantinos Petrovas · University of Lausanne2 papers (2014–2015)Rogier W. Sanders · Scripps Research Institute2 papers (2015–2018)Claire W. Hallahan · National Institute of Allergy and Infectious Diseases2 papers (2012–2013)Andrew B. Ward · Scripps Research Institute2 papers (2024–2025)